Could the same technology that enables targeted immunotherapy for cancer be used to tackle Alzheimer's?
Inspired by advances in cancer therapy, a team at the Buck Institute has engineered immune cells equipped with specialized targeting devices called chimeric antigen receptors (CARs) that can distinguish and respond to tau ...
Jun 12, 2025
0
21
